Jacob L Edmondson
Researcher
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Jacob L. Edmondson's research focuses on the molecular mechanisms underlying cancer progression and the development of anti-tumor immunity. His work investigates the role of specific proteins, such as NEK2 and EZH2, in tumorigenesis and how their modulation can impact cancer development. Edmondson also studies the activation of cellular pathways, like ATF6, and their influence on the immune response to cancer, particularly in the context of melanoma.
Further research areas include the dynamics of proteome turnover in T cell exhaustion, aiming to identify factors that enhance T cell persistence. He also examines the impact of metabolic stress on cancer cells and the immune machinery. Edmondson has published 14 works, with a total of 130 citations and an h-index of 3. He has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Brian Koss, Daniel Fil, Megan R. Reed, and Billie Heflin.
Metrics
- h-index: 3
- Publications: 14
- Citations: 133
Selected Publications
-
Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy (2026)
-
691 ATF6 activation promotes ICB response in melanoma (2025)
-
762 CD28 costimulation induces PCK2 to support T cell effector function in metabolically hostile environments (2025)
-
277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion (2025)
-
Comprehensive Analysis of Proteome Turnover Dynamics During T Cell Exhaustion (2025)
-
EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanoma (2025)
-
1132 Enhancing melanoma therapy efficacy by protecting EZH2 activity in T cells (2024)
-
538 ATF6 activation in melanoma promotes anti-tumor immunity and improves ICB therapy response (2024)
-
319 Comprehensive analysis of proteome turnover dynamics during T cell exhaustion (2024)
-
932 Defining the role for PCK2 in T-cell metabolic plasticity (2024)
-
Role of NEK2 in tumorigenesis and tumor progression (2024)
-
Abstract 584: Synergistic action of ATF6 and EZH2 in sensing metabolic stress to boost anti-tumor immunity (2024)
-
536 EZH2 senses metabolic stress to restore MHC-I antigen presentation and ICB response in metastatic melanoma (2023)
-
Abstract LB041: EZH2 and ATF6 sense metabolic stress to balance MHC class I antigen presentation in melanoma (2023)
-
Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression (2020)
Collaboration Network
Top Collaborators
- Role of NEK2 in tumorigenesis and tumor progression
- EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanoma
- Abstract LB041: EZH2 and ATF6 sense metabolic stress to balance MHC class I antigen presentation in melanoma
- 536 EZH2 senses metabolic stress to restore MHC-I antigen presentation and ICB response in metastatic melanoma
- Abstract 584: Synergistic action of ATF6 and EZH2 in sensing metabolic stress to boost anti-tumor immunity
Showing 5 of 13 shared publications
- EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanoma
- 536 EZH2 senses metabolic stress to restore MHC-I antigen presentation and ICB response in metastatic melanoma
- Abstract 584: Synergistic action of ATF6 and EZH2 in sensing metabolic stress to boost anti-tumor immunity
- 932 Defining the role for PCK2 in T-cell metabolic plasticity
- 538 ATF6 activation in melanoma promotes anti-tumor immunity and improves ICB therapy response
Showing 5 of 10 shared publications
- EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanoma
- Abstract LB041: EZH2 and ATF6 sense metabolic stress to balance MHC class I antigen presentation in melanoma
- 536 EZH2 senses metabolic stress to restore MHC-I antigen presentation and ICB response in metastatic melanoma
- Abstract 584: Synergistic action of ATF6 and EZH2 in sensing metabolic stress to boost anti-tumor immunity
- 319 Comprehensive analysis of proteome turnover dynamics during T cell exhaustion
Showing 5 of 9 shared publications
- EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanoma
- Abstract LB041: EZH2 and ATF6 sense metabolic stress to balance MHC class I antigen presentation in melanoma
- 536 EZH2 senses metabolic stress to restore MHC-I antigen presentation and ICB response in metastatic melanoma
- Abstract 584: Synergistic action of ATF6 and EZH2 in sensing metabolic stress to boost anti-tumor immunity
- 538 ATF6 activation in melanoma promotes anti-tumor immunity and improves ICB therapy response
Showing 5 of 7 shared publications
- EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanoma
- Abstract LB041: EZH2 and ATF6 sense metabolic stress to balance MHC class I antigen presentation in melanoma
- 536 EZH2 senses metabolic stress to restore MHC-I antigen presentation and ICB response in metastatic melanoma
- Abstract 584: Synergistic action of ATF6 and EZH2 in sensing metabolic stress to boost anti-tumor immunity
- 538 ATF6 activation in melanoma promotes anti-tumor immunity and improves ICB therapy response
Showing 5 of 7 shared publications
- 932 Defining the role for PCK2 in T-cell metabolic plasticity
- 319 Comprehensive analysis of proteome turnover dynamics during T cell exhaustion
- Comprehensive Analysis of Proteome Turnover Dynamics During T Cell Exhaustion
- 277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion
- 762 CD28 costimulation induces PCK2 to support T cell effector function in metabolically hostile environments
Showing 5 of 6 shared publications
- 932 Defining the role for PCK2 in T-cell metabolic plasticity
- 319 Comprehensive analysis of proteome turnover dynamics during T cell exhaustion
- Comprehensive Analysis of Proteome Turnover Dynamics During T Cell Exhaustion
- 277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion
- 762 CD28 costimulation induces PCK2 to support T cell effector function in metabolically hostile environments
- 932 Defining the role for PCK2 in T-cell metabolic plasticity
- 319 Comprehensive analysis of proteome turnover dynamics during T cell exhaustion
- Comprehensive Analysis of Proteome Turnover Dynamics During T Cell Exhaustion
- 277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion
- 762 CD28 costimulation induces PCK2 to support T cell effector function in metabolically hostile environments
- 932 Defining the role for PCK2 in T-cell metabolic plasticity
- 538 ATF6 activation in melanoma promotes anti-tumor immunity and improves ICB therapy response
- 762 CD28 costimulation induces PCK2 to support T cell effector function in metabolically hostile environments
- 691 ATF6 activation promotes ICB response in melanoma
- EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanoma
- 932 Defining the role for PCK2 in T-cell metabolic plasticity
- 319 Comprehensive analysis of proteome turnover dynamics during T cell exhaustion
- 277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion
- 319 Comprehensive analysis of proteome turnover dynamics during T cell exhaustion
- Comprehensive Analysis of Proteome Turnover Dynamics During T Cell Exhaustion
- 277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion
- 319 Comprehensive analysis of proteome turnover dynamics during T cell exhaustion
- Comprehensive Analysis of Proteome Turnover Dynamics During T Cell Exhaustion
- 277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion
- EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanoma
- 538 ATF6 activation in melanoma promotes anti-tumor immunity and improves ICB therapy response
- 691 ATF6 activation promotes ICB response in melanoma
- EZH2 loss during metabolic stress drives restoration of MHC class I machinery in melanoma
- Abstract LB041: EZH2 and ATF6 sense metabolic stress to balance MHC class I antigen presentation in melanoma
- 319 Comprehensive analysis of proteome turnover dynamics during T cell exhaustion
- 277 Proteome turnover dynamics analysis uncovers E3 ligases that enhance T-cell persistence during exhaustion
Similar Researchers
Based on overlapping research topics